HESTERBIO.NS Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 12:59):

Stats
Объем за сегодня	2 020.00
Средний объем	9 103.00
Рыночная капитализация	14.21B
EPS	INR0 ( 2024-02-02 )
Дата следующего отчета о доходах	( INR0 ) 2024-05-10
Last Dividend	INR8.00 ( 2023-09-13 )
Next Dividend	INR0 ( N/A )
P/E	74.24
ATR14	INR1.969 (0.12%)

Объем Корреляция

Длинно: -0.12 (neutral)

Кратко: -0.19 (neutral)

Signal:(47.598) Neutral

Hester Biosciences Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Hester Biosciences Корреляция - Валюта/Сырье

0.55
( weak )

0.64
( weak )

0.61
( weak )

0.59
( weak )

0.39
( neutral )

-0.62
( weak negative )

Hester Biosciences Финансовые показатели

Annual	2022
Выручка:	INR2.66B
Валовая прибыль:	INR1.89B (70.88 %)
EPS:	INR31.30

FY	2022
Выручка:	INR2.66B
Валовая прибыль:	INR1.89B (70.88 %)
EPS:	INR31.30

FY	2022
Выручка:	INR2.35B
Валовая прибыль:	INR1.66B (70.70 %)
EPS:	INR46.22

FY	2021
Выручка:	INR2.14B
Валовая прибыль:	INR1.58B (73.69 %)
EPS:	INR40.47

Financial Reports:

No articles found.

Hester Biosciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Hester Biosciences Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.34 - low (11.08%) | Divividend Growth Potential Score: 3.09 - Decrease likely (38.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR3.10	2015-09-10
Last Dividend	INR8.00	2023-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	INR68.10	--
Avg. Dividend % Per Year	0.31%	--
Score	1.73	--
Div. Sustainability Score	3.34
Div.Growth Potential Score	3.09
Div. Directional Score	3.22	--

Next Divdend (Est)
(2024-08-26)

INR8.28 Estimate 3.41 %

Dividend Stability

0.27 Very Poor

Dividend Score

1.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	0.65%
2019	INR7.00	0.60%
2020	INR6.60	0.46%
2021	INR10.00	0.59%
2022	INR10.00	0.40%
2023	INR8.00	0.45%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUNDARMHLD.NS	Dividend Junior	2023-07-03	Annually	7	1.35%
NATIONALUM.NS	Dividend Knight	2023-09-15	Semi-Annually	26	4.12%
HLEGLAS.NS	Dividend Junior	2023-09-21	Annually	4	0.19%
CANTABIL.NS	Dividend Junior	2023-09-15	Annually	5	0.63%
RITES.NS	Dividend Knight	2023-09-08	Quarterly	7	3.95%
LAMBODHARA.NS	Dividend Junior	2023-09-14	Annually	10	0.87%
FORCEMOT.NS	Dividend Junior	2023-09-21	Annually	6	0.45%
APLAPOLLO.NS	Ex Dividend Junior	2023-09-01	Sporadic	13	0.07%
TATVA.NS	Dividend Junior	2023-09-08	Annually	3	0.04%
NUCLEUS.NS	Dividend Junior	2023-07-07	Annually	22	1.41%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0631	1.500	8.74	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0640	1.500	-0.400	-0.600	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	3.05	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.671	1.000	2.15	2.15	[0.2 - 0.8]
operatingProfitMarginTTM	0.148	1.000	9.04	9.04	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	77.24	1.000	2.30	0	[1 - 100]
returnOnEquityTTM	0.0640	2.50	-0.257	-0.600	[0.1 - 1.5]
freeCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.477	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.39	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.29	0	[0.1 - 0.5]
Total Score				3.09

Hester Biosciences

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Обновления в реальном времени для Hester Biosciences [HESTERBIO.NS]

Upcoming Earnings Alert

Hester Biosciences Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)